MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

Search

Penumbra Inc

Închisă

SectorSănătate

311.07 -0.65

Rezumat

Modificarea prețului

24h

Curent

Minim

310.9

Maxim

314.31

Indicatori cheie

By Trading Economics

Venit

581K

46M

Vânzări

15M

355M

P/E

Medie Sector

75.153

88.032

Marjă de profit

12.927

Angajați

4,500

EBITDA

4M

55M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+7.55% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

3.5B

12B

Deschiderea anterioară

311.72

Închiderea anterioară

311.07

Sentimentul știrilor

By Acuity

50%

50%

157 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Penumbra Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

31 dec. 2025, 22:20 UTC

Principalele dinamici ale pieței

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 dec. 2025, 17:31 UTC

Principalele dinamici ale pieței

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 dec. 2025, 16:30 UTC

Principalele dinamici ale pieței

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 dec. 2025, 15:19 UTC

Principalele dinamici ale pieței

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 dec. 2025, 15:17 UTC

Principalele dinamici ale pieței

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 dec. 2025, 14:37 UTC

Principalele dinamici ale pieței

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

31 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 dec. 2025, 21:13 UTC

Achiziții, Fuziuni, Preluări

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 dec. 2025, 20:40 UTC

Market Talk

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 dec. 2025, 20:22 UTC

Market Talk

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 dec. 2025, 19:50 UTC

Market Talk

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 dec. 2025, 19:31 UTC

Market Talk

Precious Metals Cap Off Record Runs -- Market Talk

31 dec. 2025, 18:50 UTC

Market Talk

Global Equities Roundup: Market Talk

31 dec. 2025, 18:50 UTC

Market Talk

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 dec. 2025, 17:17 UTC

Market Talk

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 dec. 2025, 17:16 UTC

Principalele dinamici ale pieței

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 dec. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

31 dec. 2025, 17:00 UTC

Achiziții, Fuziuni, Preluări

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 dec. 2025, 15:57 UTC

Achiziții, Fuziuni, Preluări

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 dec. 2025, 15:54 UTC

Market Talk

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 dec. 2025, 15:02 UTC

Principalele dinamici ale pieței

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 dec. 2025, 14:40 UTC

Achiziții, Fuziuni, Preluări

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 dec. 2025, 14:20 UTC

Market Talk

Crude Futures On Track to End the Year With Losses -- Market Talk

31 dec. 2025, 13:46 UTC

Market Talk

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

31 dec. 2025, 13:01 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

31 dec. 2025, 11:10 UTC

Market Talk

Copper Remains in Touching Distance of Record Highs -- Market Talk

31 dec. 2025, 10:46 UTC

Market Talk

Euro on Track For Strong Annual Performance -- Market Talk

31 dec. 2025, 10:25 UTC

Market Talk

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

31 dec. 2025, 10:23 UTC

Market Talk

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

31 dec. 2025, 09:33 UTC

Market Talk

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Comparație

Modificare preț

Penumbra Inc Așteptări

Obiectiv de preț

By TipRanks

7.55% sus

Prognoză pe 12 luni

Medie 338 USD  7.55%

Maxim 388 USD

Minim 266 USD

În baza a 14 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPenumbra Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

14 ratings

13

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

288.28 / 292.9394Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Bullish Evidence

Termen lung

Weak Bullish Evidence

Sentiment

By Acuity

157 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat